Is OTIC or MCD a better dividend investment in 2026?

OTIC currently yields 23529.41% with a 5% 5-year dividend growth rate. MCD yields 2.34% with 8.5% growth. The better choice depends on your goal: OTIC offers higher current income.

What is the dividend yield difference between OTIC and MCD?

OTIC has a forward dividend yield of 23529.41% ($2.00/share annually). MCD yields 2.34% ($7.26/share annually). The yield gap is 23527.07 percentage points.

Home › Compare › OTIC vs MCD

OTIC vs MCD: Dividend Comparison 2026

OTIC yields 23529.41% · MCD yields 2.34%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OTIC wins by $263656825893602263040.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OTIC

● Live price

23529.41%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$263656825893602263040.00M

Annual income

$261,470,826,952,048,300,000,000,000.00

Full OTIC calculator →

MCD

McDonald's Corporation

● Live price

2.34%

Share price

$310.79

Annual div

$7.26

5Y div CAGR

42.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$77.7K

Annual income

$25,833.37

Full MCD calculator →

Portfolio growth — OTIC vs MCD

📍 OTIC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OTIC	MCD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OTIC + MCD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OTIC pays

MCD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTIC

Annual income on $10K today (after 15% tax)

$2,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$222,250,202,909,241,040,000,000,000.00/yr

MCD

Annual income on $10K today (after 15% tax)

$198.56/yr

After 10yr DRIP, annual income (after tax)

$21,958.36/yr

At 15% tax rate, OTIC beats the other by $222,250,202,909,241,040,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTIC + MCD for your $10,000?

OTIC: 50%MCD: 50%

100% MCD50/50100% OTIC

Portfolio after 10yr

$131828412946801131520.00M

Annual income

$130,735,413,476,024,150,000,000,000.00/yr

Blended yield

99.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

OTIC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$6.00

+70488.2% upside vs current

Range: $6.00 — $6.00

Altman Z

-16.9

Piotroski

2/9

MCD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$351.76

+13.2% upside vs current

Range: $320.00 — $385.00

Altman Z

4.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTIC buys

MCD buys

No recent congressional trades found for OTIC or MCD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOTICMCD

Forward yield	23529.41% ✓	2.34%
Annual dividend / share	$2.00	$7.26 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	42.3% ✓
Portfolio after 10y	$263656825893602263040.00M ✓	$77.7K
Annual income after 10y	$261,470,826,952,048,300,000,000,000.00 ✓	$25,833.37
Total dividends collected	$263512773352864874496.00M ✓	$57.7K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary
Analyst consensus	Buy	Buy
Analyst price target	$6.00	$351.76 ✓

Year-by-year: OTIC vs MCD ($10,000, DRIP)

Year	OTIC Portfolio	OTIC Income/yr	MCD Portfolio	MCD Income/yr	Gap
1← crossover	$2,363,641	$2,352,941.18	$10,812	$332.41	+$2.35M → OTIC
2	$522,296,260	$519,767,163.60	$11,819	$488.02	+$522.28M → OTIC
3	$107,898,570,132	$107,339,713,133.69	$13,111	$724.37	+$107898.56M → OTIC
4	$20,839,539,403,669	$20,724,087,933,628.63	$14,832	$1,091.05	+$20839539.39M → OTIC
5	$3,763,094,738,299,595	$3,740,796,431,137,668.50	$17,219	$1,675.85	+$3763094738.28M → OTIC
6	$635,328,756,192,409,300	$631,302,244,822,428,800.00	$20,688	$2,641.85	+$635328756192.39M → OTIC
7	$100,290,713,829,320,920,000	$99,610,912,060,195,030,000.00	$25,990	$4,309.70	+$100290713829320.89M → OTIC
8	$14,802,844,275,710,542,000,000	$14,695,533,211,913,168,000,000.00	$34,590	$7,351.77	+$14802844275710542.00M → OTIC
9	$2,042,989,665,003,715,000,000,000	$2,027,150,621,628,704,700,000,000.00	$49,535	$13,285.25	+$2042989665003714816.00M → OTIC
10	$263,656,825,893,602,270,000,000,000	$261,470,826,952,048,300,000,000,000.00	$77,746	$25,833.37	+$263656825893602263040.00M → OTIC

OTIC vs MCD: Complete Analysis 2026

OTIC — Stock

Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Full OTIC Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →

📬

Get this OTIC vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTIC vs SCHD OTIC vs JEPI OTIC vs O OTIC vs KO OTIC vs MAIN OTIC vs YUM OTIC vs QSR OTIC vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.